Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - anti-d rho immunoglobulin, quantity: 250 iu; anti-d rho immunoglobulin, quantity: 10 mg/ml - injection, solution - excipient ingredients: glycine; water for injections; human immunoglobulin a - rh(d) immunoglobulin is indicated for the prevention of rh sensitisation in rh(d)negative females at or below child bearing age.

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - anti-d rho immunoglobulin, quantity: 625 iu; anti-d rho immunoglobulin, quantity: 30 mg/ml - injection, solution - excipient ingredients: glycine; water for injections; human immunoglobulin a - indications as at 6 august 2002 : rh(d) immunoglobulin is indicated for the prevention of rh sensitisation in rh(d) negative females at or below child bearing age.

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - anti-d rho immunoglobulin, quantity: 1500 iu - injection, solution - excipient ingredients: chloride; glycine; sodium; albumin - prevention of rh sensitisation in rh(d)-negative females at or below child-bearing age and treatment of rh(d)-negative persons after incompatible transfusions of rh(d)-positive blood or other products containing red blood cells.

New Zealand - English - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - anti-d [rho] immunoglobulin 250 [iu] - solution for injection - 250 iu - active: anti-d [rho] immunoglobulin 250 [iu] - rh(d) immunoglobulin-vf is indicated for the prevention of rh sensitisation in rh(d) negative females at or below child bearing age.

New Zealand - English - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - anti-d [rho] immunoglobulin 625 [iu] - solution for injection - 625 iu - active: anti-d [rho] immunoglobulin 625 [iu] excipient: glycine water for injection - rh(d) immunoglobulin-vf is indicated for the prevention of rh sensitisation in rh(d) negative females at or below child bearing age.

Israel - English - Ministry of Health

csl behring ltd., israel - anti-d immunoglobulins - solution for injection - anti-d immunoglobulins 150 mcg/ml - anti-d (rh) immunoglobulin - anti-d (rh) immunoglobulin - prophylaxis of rh (d) immunisation in rh (d)-negative women: anti-d immune globulin is administered for the prevention of rh (d) immunization if it has been demonstrated or if it is suspected that fetal erythrocytes have entered the circulation of the mother. treatment is not necessary when it is assured that the child or the father are rh (d)- negative. criteria for a rhesus-incompatible pregnancy and the administration of anti-d immune globulin are : a) the mother is rh (d) -negative b) the child is either rh (d)-positive rh (d)weak - positive or its rhesus type is not known. routine antepartum prophylaxis : to prevent rh (d) immunisation due to spontaneous fetomaternal haemorrhage (fmh) during the last trimester of pregnancy. postpartum prophylaxis to prevent rh (d) immunisation of the rh (d)-negative mother following delivery of a rh (d)-positive child. complications of pregnancy: interventions during pregnancy such as invasive prenatal diagnosis (e.g. amniocentesis chorionic villus sampling fetal blood sampling) or other intrauterine procedures (e.g. insertion of shunts embryo reduction) external version of the fetus and therapeutic abortion. incidents during pregnancy such as antepartum haemorrhage spontaneous abortion ruptured tubal pregnancy ectopic pregnancy stillbirths intrauterine death and abdominal trauma. treatment of rh (d) -negative persons after incompatible transfusions of rh (d)-positive blood or erythrocyte concentrate: prevention of rh (d) immunisation in rh (d)-negative persons who for any reason have been given blood or blood components containing rh (d)-positive red cells.

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - anti-d rho immunoglobulin, quantity: 625 iu; human immunoglobulin g, quantity: 10 mg/ml - injection, solution - excipient ingredients: glycine - rh(d) immunoglobulin-vf is indicated for the prevention of rh sensitisation in rh(d) negative females at or below child bearing age.

Australia - English - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - human immunoglobulin g, quantity: 10 mg/ml; anti-d rho immunoglobulin, quantity: 250 iu - injection, solution - excipient ingredients: glycine - rh(d) immunoglobulin-vf is indicated for the prevention of rh sensitisation in rh(d) negative females at or below child bearing age.

Canada - English - Health Canada

rh pharmaceuticals inc. - anti-d (rh) immunoglobulin (human); sodium chloride - kit - 300mcg; .9% - anti-d (rh) immunoglobulin (human) 300mcg; sodium chloride .9% - serums

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

rho) immunoglobulin 1,250units/1ml solution for injection pre-filled syringes (baxter healthcare ltd - anti-d (rho) immunoglobulin - solution for injection - 1250unit/1ml